Sara Al-Dahir, PharmD, and her team in the College of Pharmacy were selected by the National Institutes of Health (NIH) to present their research on vaccine hesitancy to the Biden administration. The research project was developed in response to the NIH sending a Notice of Special Interest (NSI) offering funding for research done on COVID-19 testing in the summer of 2020. Dr. Al-Dahir’s team went the extra step to focus solely on vaccine hesitancy in the African American community. Read the full article on Xavier University’s website.
A special acknowledgement to Daniel Sarpong, PhD and Kathleen Kennedy, PharmD, who are mentioned as contributors on this research. Dr. Sarpong is the LA CaTS Center Community Engagement & Outreach Director and Dr. Kennedy serves on the LA CaTS Internal Advisory Committee. Congratulations to Dr. Al-Dahir and her study team on this honor and recognition.